Eko Health (Series D)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$264,999,999

Company Info
Founding Year
2013
Founders
Connor Landgraf
Company Description
A digital health company applying ML to fight against heart and lung disease with AI-powered digital stethoscopes. Eko Health is a leading innovator in digital health technology for heart and lung disease detection. Eko Health, Inc. (Eko) is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes and AI detection platform, SENSORA™. The company’s FDA-cleared technologies are used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.
Market
Healthcare & Wellness
Coinvestors
Morningside Group,Highland Capital,Questa Capital,ARTIS Ventures

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement